What is ARS Pharmaceuticals, Inc.'s PP&E (net)?

ARS Pharmaceuticals, Inc. (SPRY) reported PP&E (net) of $2.29M in Q1 2026.

How has ARS Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?

ARS Pharmaceuticals, Inc.'s PP&E (net) increased by 112.6% year-over-year, from $1.08M to $2.29M.

What is the long-term trend for ARS Pharmaceuticals, Inc.'s PP&E (net)?

Over 5 years (2020 to 2025), ARS Pharmaceuticals, Inc.'s PP&E (net) has grown at a 8.8% compound annual growth rate (CAGR), from $1.62M to $2.47M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

ARS Pharmaceuticals, Inc. SPRY PP&E (Net)

PP&E (Net) at other companies

Amneal Pharmaceuticals, Inc.AMRX

$444.61M+4.1%

ViatrisVTRS

$2.53B-4.1%

AMP

Amphastar PharmaceuticalsAMPH

$307.23M-0.1%

Catalyst PharmaceuticalCPRX

$994K-19.8%

Eton Pharmaceuticals, Inc.ETON

$372K+1,591%

Other financials

Income statement

See full

Revenue$22.7M+184%

Operating income-$60.1M-61.8%

Net income-$60.6M-78.6%

EPS (diluted)-$0.61-74.3%

Balance sheet

See full

Cash & equivalents$24.3M-39.0%

Total debt$96.5M+132,122%

Total equity$61.3M-73.2%

Total assets$287.6M-12.1%

Cash flow

See full

Operating cash flow-$44.9M-10.3%

CapEx--100%

Free cash flow-$44.9M-10.1%

Valuation

See full

Market cap$796.41M-48.7%

Enterprise value$868.61M-42.6%

P/S8.1×-7.9×

Profitability

See full

Operating margin-204.5%—

Net margin-200%-219pp

FCF margin-177.1%-206pp

Returns & leverage

See full

Return on equity-136.4%-144pp

Debt / equity1.6×+1.6×

Current ratio4.9×-6.1×

Where this comes from

Reported directly by ARS Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about ARS Pharmaceuticals, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ARS Pharmaceuticals, Inc.'s PP&E (net)?: ARS Pharmaceuticals, Inc. (SPRY) reported PP&E (net) of $2.29M in Q1 2026.
How has ARS Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?: ARS Pharmaceuticals, Inc.'s PP&E (net) increased by 112.6% year-over-year, from $1.08M to $2.29M.
What is the long-term trend for ARS Pharmaceuticals, Inc.'s PP&E (net)?: Over 5 years (2020 to 2025), ARS Pharmaceuticals, Inc.'s PP&E (net) has grown at a 8.8% compound annual growth rate (CAGR), from $1.62M to $2.47M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.